CR:DOI:ebbd1eb2f8fe9a223da5222d34020535

{{#scite:
 |reference=warnock2014re
 |type=journal-article
 |title=Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States
 |author=Paschalis Vergidis;Raymund R. Razonable;L. Joseph Wheat;Lynn Estes;Angela M. Caliendo;Lindsey R. Baden;John R. Wingard;John Baddley;Maha Assi;Steven Norris;Pranatharthi Chandrasekar;Ryan Shields;Hong Nguyen;Alison Freifeld;Richard Kohler;Martin Kleiman;Thomas J. Walsh;Chadi A. Hage|+sep=;
 |editor=D. W. Warnock
 |journal=Journal of Clinical Microbiology
 |publisher=American Society for Microbiology
 |year=2014
 |volume=52
 |issue=6
 |pages=2199-2201
 |doi=10.1128/jcm.00285-14
 |issn=0095-1137;1098-660X|+sep=;
 |retrieved-from=https://dx.doi.org/
 |retrieved-on=2025-07-03
}}